155 related articles for article (PubMed ID: 6101065)
1. [Lack of relationship between viral leukemogenesis and immunosuppression in the mouse].
Ruggiero RA; Dosne Pasqualini C
Rev Argent Microbiol; 1983; 15(2):119-30. PubMed ID: 6101065
[TBL] [Abstract][Full Text] [Related]
2. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
Ruddle NH; Armstrong MY; Richards FF
J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
[No Abstract] [Full Text] [Related]
3. Susceptibility and resistance to viral leukemogenesis in the mouse. IV. Mechanisms of host resistance to leukemia expression.
Tennant JR
J Natl Cancer Inst; 1972 Nov; 49(5):1257-67. PubMed ID: 4346533
[No Abstract] [Full Text] [Related]
4. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
Hirsch MS
Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
[No Abstract] [Full Text] [Related]
5. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
7. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
8. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS.
Klinken SP; Fredrickson TN; Hartley JW; Yetter RA; Morse HC
J Immunol; 1988 Feb; 140(4):1123-31. PubMed ID: 2830334
[TBL] [Abstract][Full Text] [Related]
9. Immune response to rauscher virus-induced leukemia in DBA mice. I. Role of cellular and humoral immunity in spontaneous regression.
Tóth FD; Gomba S; Váczi L; Kása M; Jakó J
Neoplasma; 1976; 23(5):471-81. PubMed ID: 980178
[TBL] [Abstract][Full Text] [Related]
10. Studies on specific humoral immunity in leukemia.
Bergolz VM
Neoplasma; 1976; 23(5):457-62. PubMed ID: 790209
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic risk of endogenous retrovirus infection in immunodeficient hosts.
Zhang F; Da R; Song W; Chen X; Zhang X; Li X; Gu H
Virus Res; 2008 Mar; 132(1-2):237-41. PubMed ID: 18178281
[TBL] [Abstract][Full Text] [Related]
12. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
13. Ecotropic murine leukemia viruses and exogenous mouse mammary tumor viruses are not essential for pristane-induced lupus.
Akaogi J; Nacionales DC; Kuroda Y; Reeves WH; Satoh M
Arthritis Rheum; 2003 Oct; 48(10):2990-2. PubMed ID: 14558108
[No Abstract] [Full Text] [Related]
14. Resistance to Friend leukemia virus in mice: effect of immunosuppression.
Stutman O; Dupuy JM
J Natl Cancer Inst; 1972 Nov; 49(5):1283-93. PubMed ID: 4405498
[No Abstract] [Full Text] [Related]
15. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
[TBL] [Abstract][Full Text] [Related]
16. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the development of experimental leukemia and animals' capacity for a humoral immune response].
Levin VI; Svirnovskii AI
Biull Eksp Biol Med; 1976 Sep; 82(9):1088-90. PubMed ID: 990463
[TBL] [Abstract][Full Text] [Related]
18. Leukemogenesis by Moloney murine leukemia virus: a multistep process.
Fan H
Trends Microbiol; 1997 Feb; 5(2):74-82. PubMed ID: 9108934
[TBL] [Abstract][Full Text] [Related]
19. Effects of pyran copolymer on leukemogenesis in immunosuppressed AKR mice.
Hirsch MS; Black PH; Wood ML; Monaco AP
J Immunol; 1973 Jul; 111(1):91-5. PubMed ID: 4351539
[No Abstract] [Full Text] [Related]
20. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
